drugset / Trial / NCT04798391
Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus
NaSingle-groupOpen-labelTreatment
Summary
Objective: To determine the effectiveness of Intratympanic dexamethasone with lignocaine in control of idiopathic tinnitus. Methodology: 264 consenting patients with idiopathic unilateral tinnitus presenting at ENT Department were assessed for tinnitus severity using Modified Tinnitus Handicap Inventory and the scores recorded and subsequently administered intratympanically 2.0 ml (milliliter's) of dexamethasone and lignocaine (1.5 ml dexamethasone + 0.5 ml 1% lignocaine). The dose was repeated twice at weekly intervals. All patients were re assessed on Modified Tinnitus Handicap Inventory two weeks after third Intratympanic administration.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-04
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 1.5 ml | Other |
| Background | Lidocaine | Other / unclassified | 0.5 ml | Other |